Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8968 |
High Similarity |
NPD6234 |
Discontinued |
0.8839 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8766 |
High Similarity |
NPD37 |
Approved |
0.8718 |
High Similarity |
NPD4967 |
Phase 2 |
0.8718 |
High Similarity |
NPD4965 |
Approved |
0.8718 |
High Similarity |
NPD4966 |
Approved |
0.858 |
High Similarity |
NPD7228 |
Approved |
0.8442 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8385 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8366 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8355 |
Intermediate Similarity |
NPD6190 |
Approved |
0.8354 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8345 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8333 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8293 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8291 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8284 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8282 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.825 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8232 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8232 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8232 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8204 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8193 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8125 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8125 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8121 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8075 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8047 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7988 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7941 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7933 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7929 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7925 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7907 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.787 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7866 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7836 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7831 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7824 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7821 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7808 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.78 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7785 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7748 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7744 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7727 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7707 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7707 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7707 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7705 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7697 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7688 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7683 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7683 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7682 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7682 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.768 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7679 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7674 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7669 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7667 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7651 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7636 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD5242 |
Approved |
0.763 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7625 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7625 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7625 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7625 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7586 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.758 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7562 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7562 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7545 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7532 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD5403 |
Approved |
0.753 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7529 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7486 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7468 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7467 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7455 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.744 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7412 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7405 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD919 |
Approved |
0.7389 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7386 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7383 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7383 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7355 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7355 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7355 |
Intermediate Similarity |
NPD943 |
Approved |
0.7349 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7349 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7345 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7345 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7342 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7342 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7342 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7338 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7333 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.733 |
Intermediate Similarity |
NPD7039 |
Approved |
0.733 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7329 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7318 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7315 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7299 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7292 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7267 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7261 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7261 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7257 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7253 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD6746 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7233 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7229 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7229 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7209 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7205 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.72 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7197 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7197 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7188 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7188 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7186 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7181 |
Intermediate Similarity |
NPD17 |
Approved |
0.7179 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7171 |
Intermediate Similarity |
NPD1283 |
Approved |
0.717 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7168 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7153 |
Intermediate Similarity |
NPD228 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5958 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7126 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7114 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7108 |
Intermediate Similarity |
NPD920 |
Approved |
0.7089 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7078 |
Intermediate Similarity |
NPD5647 |
Approved |
0.707 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7069 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7069 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7048 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7047 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7047 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7037 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.7033 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7032 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7026 |
Intermediate Similarity |
NPD7827 |
Phase 1 |
0.7025 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7014 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7014 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7013 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7013 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7012 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD5585 |
Approved |
0.6994
|
Remote Similarity |
NPD2800 |
Approved |